Telmisartan Only Product in Oral Dose Form

TERMINATED · PHASE2 · Panic Disorder, Mental Illness

Decision to terminate study due to a lack of efficacy in this study population. There were no safety concerns identified that contributed to this decision.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.